Jove
Visualize
Contact Us

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
What is Natural Selection?01:32

What is Natural Selection?

126.6K
Natural selection is an evolutionary process in which individuals with survival-promoting traits reproduce at higher rates. These favorable traits become more common within a population or species. Naturally selected traits initially arise via random genetic mutations. In order for selection to occur, there must be variation within a population, the trait controlling the variation must be heritable, and there must be an evolutionary advantage for variation in the trait.
126.6K
Clathrin Coated Vesicles01:12

Clathrin Coated Vesicles

9.2K
Clathrin-coated vesicles use endocytosis to transport receptors and lysosomal hydrolases from the Golgi to the lysosome in the late secretory pathway. Clathrin-mediated endocytosis was the first described endocytic process, and Clathrin-coated vesicles remain one of the most well-studied transport vesicles. The molecular machinery that generates clathrin-coated vesicles comprises over 50 proteins that precisely coordinate vesicle formation. Cell surface receptors concentrated in indented sites...
9.2K
COP Coated Vesicles00:59

COP Coated Vesicles

17.4K
Membrane-enclosed structures called vesicles transport proteins and lipids across the cell. The vesicles derive their cargo from the plasma membrane, Golgi, ER, or endosome. Coated vesicles are spherical, protein-coated carriers with a 50–100 nm diameter that mediate bidirectional transport between the ER and the Golgi. The distribution of proteins between the ER and Golgi complex is dynamic and is maintained by different coated vesicles. Their formation is driven by the assembly of...
17.4K
Coat Assembly and GTPases01:33

Coat Assembly and GTPases

4.3K
Vesicles incorporate different coat protein subunits in different cell locations, which changes the properties of the coat, such as the shape and geometry of the transport vesicles. Thus, vesicle coat proteins also play a significant role in cargo selection.
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...
4.3K
Pinching-off of Coated Vesicles01:32

Pinching-off of Coated Vesicles

4.0K
Vesicle budding is orchestrated by distinct cytosolic proteins such as adaptor proteins, coat proteins, and GTPases. To initiate vesicle budding, membrane-bending proteins containing crescent-shaped BAR domains bind to the lipid heads in the bilayer and distort the membrane to form a protein-coated vesicle bud. Adaptors proteins such as AP2 for clathrin-coated vesicles can nucleate on the deformed membrane. Finally, coat proteins such as clathrin or COPI and COPII assemble into a coat forming...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthetic Mammalian RNA-Based Auxiliary Module for High Gene Expression.

ACS synthetic biology·2025
Same author

Green/red fluorescent protein disrupting drugs for real-time permeability tracking in three-dimensional tumor spheroids.

Bioengineering & translational medicine·2025
Same author

Extending the boundaries of cancer therapeutic complexity with literature text mining.

Artificial intelligence in medicine·2023
Same author

Prediction of cancer nanomedicines self-assembled from meta-synergistic drug pairs.

Journal of controlled release : official journal of the Controlled Release Society·2023
Same author

Polydopamine Copolymers for Stable Drug Nanoprecipitation.

International journal of molecular sciences·2022
Same author

Automated discovery of nanomaterials via drug aggregation induced emission.

Biomaterials·2022
Same journal

Tuning Piezoelectricity and Pyroelectricity in Poly(vinylidene fluoride) through Ionic Liquid Anion-Size Directed Polymorph and Interface Engineering.

ACS applied materials & interfaces·2026
Same journal

Adsorption-Induced Ferroelectric Symmetry Breaking in Two-Dimensional CuInP<sub>2</sub>S<sub>6</sub>.

ACS applied materials & interfaces·2026
Same journal

Nanocomplexes Integrated into a Polymeric Bilayer Film Enhance Buccal Permeation of a GLP-1 Peptide Analogue.

ACS applied materials & interfaces·2026
Same journal

Correction to "Multienzyme Active Nanozyme for Efficient Sepsis Therapy through Modulating Immune and Inflammation Inhibition".

ACS applied materials & interfaces·2026
Same journal

A Programmable Perfusion Platform with Temperature Monitoring Achieves Multiscale Cryopreservation.

ACS applied materials & interfaces·2026
Same journal

Oral Delivery of Mesenchymal Stem Cell-Derived Extracellular Vesicles To Treat Intestinal Inflammation.

ACS applied materials & interfaces·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 27, 2026

Bio-inspired Polydopamine Surface Modification of Nanodiamonds and Its Reduction of Silver Nanoparticles
07:58

Bio-inspired Polydopamine Surface Modification of Nanodiamonds and Its Reduction of Silver Nanoparticles

Published on: November 14, 2018

8.7K

Structure-Selective Polydopamine Coating on Drug Nanoparticles.

Danna Niezni1, Dana Meron Azagury1, Maytal Avrashami1

  • 1Department of Biomedical Engineering Technion - Israel Institute of Technology, Haifa, 32000, Israel.

ACS Applied Materials & Interfaces
|January 26, 2026
PubMed
Summary
This summary is machine-generated.

Polydopamine (PDA) coating is selective for small molecule drugs, challenging its universal adhesion. Molecular structure, particularly nitrogen content, dictates PDA coating behavior for improved nanoparticle stability and drug delivery.

Keywords:
decision treedrug deliverynanomedicinenanoparticlesnanoprecipitationpolydopamine

More Related Videos

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay
12:31

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay

Published on: February 28, 2015

15.6K
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.4K

Related Experiment Videos

Last Updated: Jan 27, 2026

Bio-inspired Polydopamine Surface Modification of Nanodiamonds and Its Reduction of Silver Nanoparticles
07:58

Bio-inspired Polydopamine Surface Modification of Nanodiamonds and Its Reduction of Silver Nanoparticles

Published on: November 14, 2018

8.7K
A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay
12:31

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay

Published on: February 28, 2015

15.6K
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.4K

Area of Science:

  • Materials Science
  • Nanotechnology
  • Drug Delivery

Background:

  • Polydopamine (PDA) is known for its universal, substrate-independent adhesion properties.
  • Current understanding suggests PDA adhesion is governed by hydrophobic and π-π interactions.
  • The non-specific nature of PDA coating limits precise control in complex formulations.

Purpose of the Study:

  • To investigate the selectivity of polydopamine (PDA) coating on small molecule drugs.
  • To challenge the paradigm of PDA's universal, substrate-independent adhesion.
  • To develop a predictive model for PDA coating behavior based on drug molecular structure.

Main Methods:

  • Systematic screening of 30 chemotherapeutic agents within IR783-stabilized nanoparticles.
  • Utilized Dragon molecular descriptors and principal component analysis for structure-property relationship analysis.
  • Developed and validated a decision tree model based on nitrogen content and bonding topology.

Main Results:

  • PDA coating exhibited significant structure-dependent variations, contradicting universal adhesion.
  • A predictive model based on nitrogen percentage and N-C-N motifs achieved 80% classification accuracy.
  • PDA coating improved colloidal stability and reduced aggregation of representative drugs (trametinib, dasatinib) without affecting drug release.
  • In vivo studies showed enhanced efficacy and formulation stability of PDA-coated drugs in HCT116 xenografts.

Conclusions:

  • PDA coating selectivity is a previously unrecognized phenomenon driven by molecular structure, not just conventional interactions.
  • The developed computational model enables rational design of PDA-coated nanoparticles for targeted applications.
  • This discovery expands the understanding of PDA surface chemistry and its application in nanomedicine.